New job openings in 2022 We are currently looking for 6 talented individuals to join our team! 2 Clinical Project Managers4 Clinical Research...

We are pleased to inform that our ISO 9001: 2015 certification was successfully renewed, demonstrating that our company is capable of continuously...

Starting on December 6th, Dr. Pieter Smits joins our Board of Directors. We are delighted to have him join the organization. Pieter C. Smits, M.D.,...

We were delighted to attend the latest edition of PCR London Valves as a Research Partner. 3 exciting days to learn, interact and network with the...

CERC Team will be happy to welcome you physically at PCR London, CERC booth...

As a physician, I was always passionate about science and evidence. During the 27 years with Terumo, I was blessed with the opportunity to...

Excellent News for Colibri trial: the 1st recruited patient has been treated successfully on 15th September at the Clinique Pasteur Toulouse , by a...

The results of this huge trial were presented: On 08/28 at 2:00 p.m. on the Prime Time channel of the #ESCCongress, by Pr Marco Valgimigli, and...

CERC has adopted a new corporate form integrating the concept of a company with a mission (Entreprise à Mission). This new corporate form reaffirms...

🔎How the story began, what’s David Hildick-Smith (PI of the trial) interpretation, what are the next steps… You’d like to...

Post-Market Clinical Follow-up (PMCF) is an essential component of Post-Market Surveillance applying to almost all medical devices under the New...

CERC is very proud to announce that its CEO Marie-Claude Morice, has received during EuroPCR 2021 the Andreas Grüntzig Ethica award, « in...

CERC is a long-standing partner of EuroPCR. In this year of change, there was no way we were going to miss the event! 2 CERC trials are presented:...

Learn about our COMPARE-ABSORB trial and Click here to download the results presented at CRT 2021.  ...

CERC is happy to announce the integration of a new function in the ARC HBR smartphone app. Its aim is to evaluate the individual trade-off between...

By Olivier Varenne, PI of the trial The CAOCT study is an investigator-initiated trial held thanks to a grant from Abbott Vascular and consists of a...

« Medical imaging has advanced considerably over the last 40 years since the first angioplasty was performed and now plays an important role in the...

Enjoy the replay of #aictPCR session about Complications, with our CERC and CERC Asia experts!   👉 https://bit.ly/2WvInvG...

The ABILITY Diabetes Global study comparing the ABLUMINUS Sirolimus eluting stent from Concept Medical to the XIENCE Everolimus Eluting stent from...

CERC is very proud of its Corelab Manager Antoinette Neylon who participated in PCR Valves e-course opening ceremony! At PCR Valves was also...

CERC has developped its own highly secured and perfectly efficient e-Visits tool, in order to achieve e-visits with complete confidence. This new...

Database was successfully locked on August 7th, 2020! The long-awaited results of the SCOPE II study will be presented during the late breaking...

  “Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI” : The second ARC HBR document has just been published last week !...

  We are pleased to announce the arrival of our new trial, the ELECTRODUCER trial. It has just been initiated at sites. Click on the logo below...

CERC is happy to announce that Concept Medical have entrusted CERC (Massy, France) and Icahn School of Medicine at Mount Sinai (NYC, USA) with the...

It’s a great pleasure to announce that CERC board has welcomed 3 brilliant new members: Drs Thomas Cuisset (France), Darren Mylotte (Ireland) and...

  Investigating the risk balance of thrombotic and bleeding events after percutaneous coronaryintervention (PCI) is especially relevant for...

Discover our new study CRUZ HBR Registry ! The first patient enrollment was announced on LinkedIn and Twitter by our partner SMT. Clic on the...

Marie-Claude Morice with CERC team members @ High Tech Cardio 2020 in...

CERC will be glad to meet you in England for PCR London Valves! (Link on the...

CERC has started to implement the Colibri Heart Valve CE mark trial. This balloon-expandable THV was designed with an original leaflet geometry and...

CERC is very proud to announce the launch of a new app designed to help identify High Bleeding Risk patients : ARC HBR As a member of the Academic...

CERC was founded in 2008 by a group of interventional cardiologists who firmly believed in the need for establishing a new CRO dedicated to...

CERC was proud to organize the first ARC HBR meeting in Washington’s American College of Cardiology last Friday 13th of April...

CERC will be present at TCT Denver, Colorado, feel free to come visit us at Booth (number to be confirmed) Presentation of results : Late...